KSHV-Ori-Lyt-Dependent DNA Replication

KSHV-Ori-Lyt 依赖性 DNA 复制

基本信息

  • 批准号:
    7419502
  • 负责人:
  • 金额:
    $ 39.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), is a human pathogen responsible for several AIDS associated malignancies including Kaposi's sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). Increasing evidence suggests that the lytic life cycle of the virus plays a critical role in the development of KS and other KSHV-associated diseases. In KS lesions, constant lytic replication sustains the population of latently infected cells that otherwise are quickly lost by segregation of latent viral episomes as spindle cells divide. Lytic DNA replication of herpesviruses requires both cis-acting element, the origin, and trans-acting factors including virally encoded origin-binding proteins, core replication machinery proteins and cellular factors. In addition, some epigenetic effects such as nuclear location, chromosome structure and RNA transcription influence DNA replication. To understand KSHV lytic DNA replication, we recently identified two ori-Lyts in the KSHV genome and characterized several critical cis-acting elements in the ori-Lyts. Furthermore, two regulatory proteins, K8 and RTA, were found to bind to the origins and their roles in initiation of DNA replication were investigated. These discoveries set a foundation for further investigation into the mechanism of KSHV lytic DNA replication that will be explored in the studies proposed here. In next funding period, emphasis will be placed on initiation of KSHV ori-Lyt-associated DNA replication. (1) We will characterize KSHV DNA replication complex. Roles of K8 and RTA in the complex formation or recruitment of the complex onto ori-Lyt will be investigated. (2) Many cellular proteins that might be involved in KSHV DNA replication have been identified. Two cellular proteins that may involve origin DNA unwinding and nuclear matrix attachment will be further studied because these two events are believed to be antecedent steps before replication fork formation. (3) We will study interplay between ori-Lyt-associated transcription and DNA replication. We will test the hypothesis that the transcription alters either DNA or chromatin structure and facilitates initiation of DNA replication. The results will greatly enhance our understanding on mechanisms that regulate initiation of KSHV replication. In addition, the studies will lead to new therapeutic strategies to block KSHV DNA replication and to treat KSHV-related diseases. This proposal represents the effects of our laboratory in understanding mechanisms that control and regulate KSHV lytic DNA replication. We will investigate the initiation of DNA replication in three aspects, i.e. formation of viral replisomes and their recruitment onto ori-Lyt, involvement of cellular factors in viral DNA replication and regulation of viral DNA replication by epigenetic effects. The study aims to new therapeutic strategies to block KSHV replication and treat KSHV-associated human diseases PUBLIC HEALTH RELEVANCE This proposal represents the effects of our laboratory in understanding mechanisms that control and regulate KSHV lytic DNA replication. We will investigate the initiation of DNA replication in three aspects, i.e. formation of viral replisomes and their recruitment onto ori-Lyt, involvement of cellular factors in viral DNA replication and regulation of viral DNA replication by epigenetic effects. The study aims to new therapeutic strategies to block KSHV replication and treat KSHV-associated human diseases.
卡波西肉瘤相关疱疹病毒(KSHV),也被称为人类疱疹病毒-8 (HHV-8),是一种人类病原体,可导致几种艾滋病相关恶性肿瘤,包括卡波西肉瘤(KS)、原发性积液性淋巴瘤(PEL)和多中心Castleman病(MCD)。越来越多的证据表明,病毒的裂解生命周期在KS和其他kshv相关疾病的发展中起着关键作用。在KS病变中,持续的裂解复制维持了潜伏感染细胞的数量,否则在梭形细胞分裂时,潜伏病毒发作的分离会使潜伏感染细胞迅速消失。疱疹病毒的裂解DNA复制需要顺式作用元件、起始点和反式作用因子,包括病毒编码的起始点结合蛋白、核心复制机制蛋白和细胞因子。此外,细胞核位置、染色体结构和RNA转录等表观遗传效应也影响DNA复制。为了了解KSHV裂解DNA的复制,我们最近在KSHV基因组中鉴定了两个ori-Lyts,并鉴定了ori-Lyts中几个关键的顺式作用元件。此外,我们还发现两个调控蛋白K8和RTA与起源结合,并研究了它们在DNA复制起始中的作用。这些发现为进一步研究KSHV裂解DNA复制的机制奠定了基础,这将在这里提出的研究中进行探索。在下一个资助期内,重点将放在启动KSHV oli - lyt相关DNA复制上。(1)我们将对KSHV DNA复制复合体进行表征。K8和RTA在复合物形成或复合物募集到ori-Lyt中的作用将被研究。(2)许多可能参与KSHV DNA复制的细胞蛋白已经被鉴定出来。两种可能涉及起源DNA解绕和核基质附着的细胞蛋白将进一步研究,因为这两个事件被认为是复制叉形成之前的先决步骤。(3)研究ori- lyt相关转录与DNA复制之间的相互作用。我们将测试转录改变DNA或染色质结构并促进DNA复制起始的假设。这一结果将极大地增强我们对调控KSHV复制起始机制的理解。此外,这些研究将导致新的治疗策略,以阻止KSHV DNA复制和治疗KSHV相关疾病。这一建议代表了我们的实验室在理解控制和调节KSHV裂解DNA复制的机制方面的作用。我们将从病毒复制体的形成及其在ori-Lyt上的募集、细胞因子参与病毒DNA复制以及表观遗传效应对病毒DNA复制的调控三个方面探讨DNA复制的起始。该研究旨在寻找新的治疗策略来阻断KSHV复制并治疗与KSHV相关的人类疾病。这一建议代表了我们实验室在理解控制和调节KSHV裂解DNA复制的机制方面的作用。我们将从病毒复制体的形成及其在ori-Lyt上的募集、细胞因子参与病毒DNA复制以及表观遗传效应对病毒DNA复制的调控三个方面探讨DNA复制的起始。该研究旨在寻找新的治疗策略来阻断KSHV的复制和治疗KSHV相关的人类疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAN YUAN其他文献

YAN YUAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAN YUAN', 18)}}的其他基金

Roles of KSHV Tegument Proteins in Virion Assembly
KSHV 外皮蛋白在病毒粒子组装中的作用
  • 批准号:
    9900577
  • 财政年份:
    2018
  • 资助金额:
    $ 39.38万
  • 项目类别:
KSHV-encoded Small Peptites
KSHV 编码的小肽
  • 批准号:
    8603842
  • 财政年份:
    2013
  • 资助金额:
    $ 39.38万
  • 项目类别:
Recombinant Virus and Vector Core
重组病毒和载体核心
  • 批准号:
    8541141
  • 财政年份:
    2013
  • 资助金额:
    $ 39.38万
  • 项目类别:
KSHV-encoded Small Peptites
KSHV 编码的小肽
  • 批准号:
    8542364
  • 财政年份:
    2013
  • 资助金额:
    $ 39.38万
  • 项目类别:
KSHV Abortive Replication Following De Novo Infection
从头感染后 KSHV 复制失败
  • 批准号:
    8541136
  • 财政年份:
    2013
  • 资助金额:
    $ 39.38万
  • 项目类别:
Role ofK8 bZip Protein in KSHV Lytic DNA Replication
K8 bZip 蛋白在 KSHV 裂解性 DNA 复制中的作用
  • 批准号:
    7021450
  • 财政年份:
    2002
  • 资助金额:
    $ 39.38万
  • 项目类别:
Role ofK8 bZip Protein in KSHV Lytic DNA Replication
K8 bZip 蛋白在 KSHV 裂解性 DNA 复制中的作用
  • 批准号:
    6708349
  • 财政年份:
    2002
  • 资助金额:
    $ 39.38万
  • 项目类别:
KSHV-Ori-Lyt-Dependent DNA Replication
KSHV-Ori-Lyt 依赖性 DNA 复制
  • 批准号:
    8265959
  • 财政年份:
    2002
  • 资助金额:
    $ 39.38万
  • 项目类别:
KSHV-Ori-Lyt-Dependent DNA Replication
KSHV-Ori-Lyt 依赖性 DNA 复制
  • 批准号:
    7578184
  • 财政年份:
    2002
  • 资助金额:
    $ 39.38万
  • 项目类别:
Role of K8 bZip Protein in KSHV Lytic DNA Replication
K8 bZip 蛋白在 KSHV 裂解性 DNA 复制中的作用
  • 批准号:
    6553900
  • 财政年份:
    2002
  • 资助金额:
    $ 39.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了